CIBC World Markets’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $4.89M | Buy |
+20,304
| New | +$5.19M | 0.02% | 399 |
|
|
2025
Q2 | $4.76M | Buy |
18,460
+747
| +4% | +$178K | 0.03% | 376 |
|
|
2025
Q1 | $3.97M | Sell |
17,713
-5,428
| -23% | -$1.27M | 0.03% | 345 |
|
|
2024
Q4 | $5.29M | Buy |
23,141
+3,164
| +16% | +$762K | 0.03% | 348 |
|
|
2024
Q3 | $4.88M | Buy |
19,977
+1,047
| +6% | +$234K | 0.04% | 331 |
|
|
2024
Q2 | $3.62M | Buy |
18,930
+4,202
| +29% | +$853K | 0.02% | 377 |
|
|
2024
Q1 | $2.92M | Sell |
14,728
-4,202
| -22% | -$770K | 0.02% | 418 |
|
|
2023
Q4 | $3.26M | Buy |
18,930
+10,820
| +133% | +$1.66M | 0.02% | 424 |
|
|
2023
Q3 | $1.2M | Sell |
8,110
-9,117
| -53% | -$1.65M | 0.01% | 444 |
|
|
2023
Q2 | $3.76M | Buy |
17,227
+9,798
| +132% | +$2.18M | 0.03% | 349 |
|
|
2023
Q1 | $1.63M | Sell |
7,429
-9,792
| -57% | -$2.12M | 0.03% | 402 |
|
|
2022
Q4 | $3.58M | Buy |
17,221
+14,999
| +675% | +$3.3M | 0.02% | 387 |
|
|
2022
Q3 | $485K | Sell |
2,222
-7,990
| -78% | -$1.82M | 0.01% | 445 |
|
|
2022
Q2 | $2.14M | Sell |
10,212
-19,871
| -66% | -$4.23M | 0.02% | 377 |
|
|
2022
Q1 | $7.29M | Buy |
30,083
+2,601
| +9% | +$629K | 0.06% | 208 |
|
|
2021
Q4 | $7.16M | Sell |
27,482
-5,353
| -16% | -$1.39M | 0.04% | 223 |
|
|
2021
Q3 | $8.65M | Buy |
32,835
+22,731
| +225% | +$6.22M | 0.06% | 204 |
|
|
2021
Q2 | $2.49M | Sell |
10,104
-3,772
| -27% | -$793K | 0.02% | 390 |
|
|
2021
Q1 | $2.69M | Sell |
13,876
-12,826
| -48% | -$2.57M | 0.02% | 399 |
|
|
2020
Q4 | $5.68M | Buy |
26,702
+9,254
| +53% | +$1.85M | 0.03% | 337 |
|
|
2020
Q3 | $2.99M | Buy |
17,448
+3,254
| +23% | +$601K | 0.03% | 365 |
|
|
2020
Q2 | $2.73M | Buy |
14,194
+3,671
| +35% | +$601K | 0.03% | 338 |
|
|
2020
Q1 | $1.55M | Sell |
10,523
-6,486
| -38% | -$1.03M | 0.02% | 382 |
|
|
2019
Q4 | $2.64M | Sell |
17,009
-34,662
| -67% | -$5M | 0.02% | 527 |
|
|
2019
Q3 | $6.98M | Buy |
51,671
+18,906
| +58% | +$2.48M | 0.07% | 274 |
|
|
2019
Q2 | $4M | Sell |
32,765
-1,538
| -4% | -$170K | 0.03% | 450 |
|
|
2019
Q1 | $3.57M | Sell |
34,303
-11,914
| -26% | -$1.23M | 0.03% | 397 |
|
|
2018
Q4 | $5.26M | Buy |
46,217
+6,749
| +17% | +$723K | 0.05% | 291 |
|
|
2018
Q3 | $4.55M | Buy |
39,468
+7,746
| +24% | +$848K | 0.04% | 364 |
|
|
2018
Q2 | $3.29M | Buy |
31,722
+5,229
| +20% | +$529K | 0.03% | 455 |
|
|
2018
Q1 | $2.61M | Sell |
26,493
-5,097
| -16% | -$482K | 0.03% | 434 |
|
|
2017
Q4 | $2.67M | Buy |
31,590
+9,730
| +45% | +$804K | 0.02% | 487 |
|
|
2017
Q3 | $1.68M | Buy |
+21,860
| New | +$1.67M | 0.02% | 482 |
|
Other funds holding RMD
CIBC World Markets's RMD Position: Q4 2025 in Review
CIBC World Markets opened a new position in ResMed (RMD) in Q4 2025: 20,304 shares worth $4.89M. The stake represents 0.02% of the portfolio and ranks #399 among its holdings. This is a return to the name: CIBC World Markets previously reported a position in RMD as recently as Q2 2025.
CIBC World Markets first reported a position in RMD in Q3 2017 and has held it in 33 quarters since. The position peaked at $8.65M in Q3 2021. 945 funds tracked by Wall St. Rank hold RMD as of Q4 2025.
- CIBC World Markets held 20,304 shares of ResMed worth $4.89M as of Q4 2025.
- ResMed was a new CIBC World Markets position in Q4 2025.
- ResMed made up 0.02% of CIBC World Markets's portfolio in Q4 2025, its #399 holding.
- CIBC World Markets first reported a position in ResMed in Q3 2017 and has held it in 33 quarters since.
- CIBC World Markets's ResMed position peaked at $8.65M in Q3 2021.
- 945 funds tracked by Wall St. Rank held ResMed as of Q4 2025.
Based on CIBC World Markets's 13F filing for Q4 2025, filed 12 Feb 2026.